The caspase‐derived C‐terminal fragment of βAPP induces caspase‐independent toxicity and triggers selective increase of Aβ42 in mammalian cells
- 1 September 2001
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 78 (5) , 1153-1161
- https://doi.org/10.1046/j.1471-4159.2001.00513.x
Abstract
During its physiopathological maturation, the β-amyloid precursor protein undergoes several distinct proteolytic events by activities called secretases. In Alzheimer's disease, the main histological hallmark called senile plaque is clearly linked to the overproduction of the amyloid peptides Aβ40 and Aβ42, two highly aggregable βAPP-derived fragments generated by combined cleavages by β- and γ-secretases. Recently, an alternative hydrolytic pathway was described, involving another category of proteolytic activities called caspases, responsible for the production of a 31 amino acids βAPP C-terminal fragment called C31. C31 was reported to lower the viability of N2a cells but the exact mechanisms mediating C31-toxicity remained to be established. Here we show that the transient transfection of pSV2 vector encoding C31 lowers by about 80% TSM1 neuronal cells viability. Arguing against a C31-stimulated apoptotic response, we demonstrate by combined enzymatic and immunological approaches that C31 expression did not modulate basal or staurosporine-induced caspase 3-like activity and pro-caspase-3 activation. Furthermore, C31 did not modify Bax and p53 expressions, poly-(ADP-ribose)-polymerase cleavage and cytochrome c translocation into the cytosol. However, we established that C31 overexpression triggers selective increase of Aβ42 but not Aβ40 production by HEK293 cells expressing wild-type βAPP751. Altogether, our data demonstrate that C31 induces a caspase-independent toxicity in TSM1 neurons and potentiates the pathogenic βAPP maturation pathway by increasing selectively Aβ42 species in wild type-βAPP-expressing human cells.Keywords
This publication has 46 references indexed in Scilit:
- Modulation of Amyloid Precursor Protein Metabolism by X11α/Mint-1Journal of Biological Chemistry, 2000
- Role of the proteasome in Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Proprotein Convertase Activity Contributes to the Processing of the Alzheimer's β‐Amyloid Precursor Protein in Human Cells: Evidence for a Role of the Prohormone Convertase PC7 in the Constitutive ‐Secretase PathwayJournal of Neurochemistry, 1999
- The X11α Protein Slows Cellular Amyloid Precursor Protein Processing and Reduces Aβ40 and Aβ42 SecretionJournal of Biological Chemistry, 1998
- Constitutive and Protein Kinase C‐Regulated Secretory Cleavage of Alzheimer's β‐Amyloid Precursor Protein: Different Control of Early and Late Events by the ProteasomeJournal of Neurochemistry, 1997
- Programmed Cell Death in the Developing Nervous SystemNeuron, 1996
- APP-BP1, a Novel Protein That Binds to the Carboxyl-terminal Region of the Amyloid Precursor ProteinPublished by Elsevier ,1996
- The Amyloid Peptide and Its Precursor in Alzheimer's DiseaseReviews in the Neurosciences, 1995
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976